ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 218 filers reported holding ALKERMES PLC in Q4 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42,590 | -9.9% | 1,520,485 | +0.7% | 0.01% | -14.3% |
| Q2 2023 | $47,246 | +8.6% | 1,509,446 | -2.2% | 0.01% | 0.0% |
| Q1 2023 | $43,508 | +6.0% | 1,543,351 | -1.7% | 0.01% | 0.0% |
| Q4 2022 | $41,032 | -100.0% | 1,570,313 | -66.5% | 0.01% | -58.8% |
| Q3 2022 | $104,666,000 | -66.3% | 4,687,171 | -55.1% | 0.02% | -56.4% |
| Q2 2022 | $311,006,000 | -43.7% | 10,439,938 | -50.3% | 0.04% | -30.4% |
| Q1 2022 | $552,512,000 | +11.3% | 21,000,095 | -1.6% | 0.06% | +24.4% |
| Q4 2021 | $496,452,000 | -24.3% | 21,343,581 | +0.4% | 0.04% | -27.4% |
| Q3 2021 | $655,851,000 | +17.1% | 21,266,241 | -6.9% | 0.06% | +19.2% |
| Q2 2021 | $560,158,000 | +26.2% | 22,844,954 | -3.8% | 0.05% | +18.2% |
| Q1 2021 | $443,737,000 | -5.7% | 23,754,638 | +0.8% | 0.04% | -8.3% |
| Q4 2020 | $470,359,000 | +21.1% | 23,576,902 | +0.6% | 0.05% | +6.7% |
| Q3 2020 | $388,434,000 | -18.9% | 23,441,993 | -5.0% | 0.04% | -25.0% |
| Q2 2020 | $478,767,000 | +37.7% | 24,672,366 | +2.4% | 0.06% | +9.1% |
| Q1 2020 | $347,606,000 | -29.0% | 24,105,829 | +0.4% | 0.06% | -12.7% |
| Q4 2019 | $489,611,000 | +7.3% | 24,000,556 | +2.6% | 0.06% | -3.1% |
| Q3 2019 | $456,268,000 | -0.2% | 23,386,344 | +15.3% | 0.06% | +1.6% |
| Q2 2019 | $457,020,000 | -36.0% | 20,275,957 | +3.6% | 0.06% | -39.0% |
| Q1 2019 | $714,435,000 | +27.4% | 19,578,930 | +3.0% | 0.10% | +10.5% |
| Q4 2018 | $560,937,000 | -29.7% | 19,008,371 | +1.1% | 0.10% | -18.1% |
| Q3 2018 | $797,890,000 | +3.4% | 18,800,419 | +0.3% | 0.12% | -1.7% |
| Q2 2018 | $771,725,000 | -21.5% | 18,749,378 | +10.5% | 0.12% | -24.4% |
| Q1 2018 | $983,107,000 | +9.1% | 16,961,824 | +3.0% | 0.16% | +6.8% |
| Q4 2017 | $900,858,000 | +1.8% | 16,460,046 | -5.4% | 0.15% | -3.3% |
| Q3 2017 | $884,906,000 | -16.4% | 17,405,699 | -4.7% | 0.15% | -20.5% |
| Q2 2017 | $1,058,357,000 | -3.4% | 18,256,986 | -2.5% | 0.19% | -7.3% |
| Q1 2017 | $1,095,381,000 | +6.9% | 18,724,454 | +1.5% | 0.20% | +0.5% |
| Q4 2016 | $1,024,902,000 | +17.8% | 18,440,121 | -0.3% | 0.20% | +16.6% |
| Q3 2016 | $869,708,000 | +7.6% | 18,492,617 | -1.1% | 0.18% | +2.3% |
| Q2 2016 | $808,268,000 | +22.4% | 18,701,252 | -3.2% | 0.17% | +21.3% |
| Q1 2016 | $660,412,000 | -49.2% | 19,315,926 | +18.0% | 0.14% | -48.4% |
| Q4 2015 | $1,299,128,000 | +35.2% | 16,365,932 | -0.1% | 0.27% | +27.6% |
| Q3 2015 | $960,856,000 | -7.0% | 16,377,303 | +1.9% | 0.21% | +0.5% |
| Q2 2015 | $1,033,683,000 | +4.9% | 16,065,948 | -0.6% | 0.21% | +4.4% |
| Q1 2015 | $985,283,000 | +4.0% | 16,160,128 | -0.1% | 0.20% | +1.5% |
| Q4 2014 | $947,739,000 | +36.5% | 16,184,068 | -0.1% | 0.20% | +32.2% |
| Q3 2014 | $694,529,000 | -14.4% | 16,200,820 | +0.5% | 0.15% | -13.1% |
| Q2 2014 | $811,727,000 | +12.6% | 16,128,089 | -1.4% | 0.18% | +8.0% |
| Q1 2014 | $720,939,000 | -46.6% | 16,351,536 | -50.7% | 0.16% | +4.5% |
| Q4 2013 | $1,349,478,000 | +134.2% | 33,189,320 | +93.7% | 0.16% | +7.6% |
| Q3 2013 | $576,094,000 | -43.3% | 17,135,455 | -51.7% | 0.14% | +5.9% |
| Q2 2013 | $1,016,746,000 | – | 35,451,420 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 7,950,000 | $148,506,000 | 14.24% |
| Krensavage Asset Management, LLC | 1,627,323 | $30,398,000 | 10.52% |
| Healthcare Value Capital, LLC | 100,000 | $1,868,000 | 4.16% |
| Camber Capital Management LP | 5,600,000 | $104,608,000 | 3.59% |
| ARMISTICE CAPITAL, LLC | 3,524,000 | $65,828,000 | 1.51% |
| CM Management, LLC | 70,000 | $1,308,000 | 0.97% |
| PRICE MICHAEL F | 305,000 | $5,697,000 | 0.68% |
| Palo Alto Investors LP | 487,100 | $9,099,000 | 0.52% |
| SEIZERT CAPITAL PARTNERS, LLC | 463,600 | $8,660,000 | 0.45% |
| Birchview Capital, LP | 35,000 | $654,000 | 0.39% |